Kingsview Wealth Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-48,505
Closed -$470K 1265
2025
Q2
$470K Buy
+48,505
New +$500K 0.01% 788
2025
Q1
Sell
-36,323
Closed -$542K 1161
2024
Q4
$542K Buy
+36,323
New +$592K 0.01% 711
2022
Q2
Sell
-6,746
Closed -$236K 891
2022
Q1
$236K Buy
6,746
+119
+2% +$4.07K 0.01% 769
2021
Q4
$202K Buy
+6,627
New +$216K 0.01% 858

Other funds holding OGN

Kingsview Wealth Management's OGN Position: Q3 2025 in Review

Kingsview Wealth Management sold out of Organon & Co (OGN) in Q3 2025, closing a stake of 48,505 shares — an estimated $470K sold.

Kingsview Wealth Management first reported a position in OGN in Q4 2021 and held it in 4 quarters. The position peaked at $542K in Q4 2024. 670 funds tracked by Wall St. Rank hold OGN as of Q3 2025.

  • Kingsview Wealth Management reported no remaining Organon & Co position as of Q3 2025 after selling out during the quarter.
  • Kingsview Wealth Management sold 48,505 Organon & Co shares in Q3 2025, an estimated $470K.
  • Kingsview Wealth Management first reported a position in Organon & Co in Q4 2021 and held it in 4 quarters.
  • Kingsview Wealth Management's Organon & Co position peaked at $542K in Q4 2024.
  • 670 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.

Based on Kingsview Wealth Management's 13F filing for Q3 2025, filed 12 Nov 2025.